Reply

Hepatology. 2020 Jun;71(6):2174-2175. doi: 10.1002/hep.31079.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Hepatitis B, Chronic*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Liver Neoplasms*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors